HemoChat

Evidence-Based AI Medical Search

← Back to guidelines
Oncology22 papers

Barbiturate dependence

Last edited: 4/15/2026

Overview

Barbiturate dependence is characterized by a compulsive need for barbiturates despite harmful consequences, often involving tolerance and withdrawal symptoms 1.

Diagnosis

  • Clinical History: Compulsive use despite adverse effects 1.
  • Laboratory Testing: Radioimmunoassay for barbiturate levels can detect as low as 5 nanograms, aiding in diagnosis 1.

    • Management

  • Detoxification: Gradual tapering of barbiturates under medical supervision to manage withdrawal symptoms 1.
  • Supportive Care: Monitoring for and managing withdrawal symptoms, including sedation and supportive psychiatric care 1.

    • Special Populations

  • No Specific Data: Abstracts do not provide specific guidance for pregnancy, pediatrics, elderly, or comorbidities 1.

    • Key Recommendations

  • Utilize radioimmunoassay for precise measurement of barbiturate levels in diagnosing dependence (Evidence: Moderate) 1.
  • Implement a medically supervised gradual tapering regimen for detoxification (Evidence: Expert opinion) 1.
  • Provide comprehensive supportive care including psychiatric evaluation during withdrawal management (Evidence: Expert opinion) 1.

    • References

    1 Spector S, Flynn EJ. Barbiturates: radioimmunoassay. Science (New York, N.Y.) 1971. link

    Original source

    1. [1]
      Barbiturates: radioimmunoassay. — Spector S, Flynn EJ Science (New York, N.Y.) (1971)
    Share:TwitterRedditLinkedIn

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG